Anika To Participate in December 2024 Investor Conferences
Anika To Participate in December 2024 Investor Conferences
BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior management will participate in the following upcoming conferences.
馬薩諸塞州貝德福德，2024年11月22日（環球新聞社） - 阿尼卡療法公司（納斯達克：ANIK），一家全球關節保護公司在早期干預骨科領域，今天宣佈高級管理層將參加以下即將舉行的會議。
36th Annual Piper Sandler Healthcare Conference in New York, NY on December 3rd. Dr. Cheryl Blanchard, President and CEO of Anika and Steve Griffin, Executive Vice President and Chief Financial Officer, are scheduled to present at 10:30am ET. Management will also participate in one-on-one investor meetings throughout the event.
第36屆派傑投資醫療保健大會將於12月3日在紐約舉行。阿尼卡總裁兼首席執行官謝麗爾·布蘭查德博士和首席財務官史蒂夫·格里芬執行副總裁將於上午10:30分進行演講。管理團隊還將在活動期間參加一對一投資者會議。
Sidoti Small-Cap Virtual Conference on December 5th. Steve Griffin, Executive Vice President and Chief Financial Officer, is scheduled to present at 10:45am ET. Mr. Griffin will also participate in one-on-one investor meetings throughout the event.
Sidoti小市值虛擬會議將於12月5日舉行。首席財務官史蒂夫·格里芬執行副總裁將於上午10:45分進行演講。格里芬先生還將參加一對一投資者會議。
The Benchmark Company 13th Annual Discovery One-on-One Investor Conference in New York, NY on December 11th. Dr. Cheryl Blanchard, President and CEO of Anika and Steve Griffin, Executive Vice President and Chief Financial Officer will participate in one-on-one investor meetings throughout the event.
Benchmark公司第13屆年度一對一投資者會議將於12月11日在紐約舉行。阿尼卡總裁兼首席執行官謝麗爾·布蘭查德博士和首席財務官史蒂夫·格里芬執行副總裁將參加一對一投資者會議。
For more information about these events or to schedule a one-on-one meeting with Anika's senior management, please contact Anika's Investor Relations at investorrelations@anika.com.
如需了解更多有關這些活動或安排與阿尼卡高級管理團隊的一對一會議，請聯繫阿尼卡的投資者關係部 investorrelations@anika.com。
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika's global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit .
Anika Therapeutics，Inc. (NASDAQ：ANIK)是一家全球聯合保護公司，爲早期干預矯形護理創造和交付有意義的進步。利用我們在透明質酸和植入物解決方案方面的核心專業知識，我們與臨床醫生合作，提供最小侵入式的產品，爲世界各地的人們恢復積極生活。我們的重點是矯形學中的高機會空間，包括骨關節炎疼痛管理、再生解決方案、運動醫學和關節表面解決方案，我們的產品在關鍵的護理場所，包括日間手術中心中進行高效輸送。Anika的全球運營總部位於馬薩諸塞州波士頓外部。有關Anika的更多信息，請訪問。
阿尼卡療法股份有限公司（納斯達克：ANIK）是一家全球關節保護公司，致力於爲早期干預骨科護理領域帶來有意義的創新。利用我們在透明質酸和植入物解決方案方面的核心專長，我們與臨床醫生合作，提供能夠恢復全球人民積極生活的微創產品。我們的重點是骨科學中的高機遇領域，包括骨關節炎疼痛管理和再生解決方案，並在包括門診手術中心在內的關鍵護理場所高效提供我們的產品。阿尼卡的全球業務總部位於馬薩諸塞州波士頓外。有關阿尼卡的更多信息，請訪問。
ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
阿尼卡, 阿尼卡療法, CINGAL, HYALOFASt, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSEt, 和 Anika 商標是 Anika Therapeutics, Inc. 或其子公司的商標，或已許可給 Anika Therapeutics, Inc. 供其使用。
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
投資者查詢：
阿尼卡療法公司
馬特·霍爾，781-457-9554
董事，企業發展和投資者關係
investorrelations@anika.com
譯文內容由第三人軟體翻譯。
